Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Active, not recruiting · NCT02691923 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain cancer, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-07-29 | NCT02691923 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Carl Zeiss Meditec, Inc. | 2 |
| David W. Roberts | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sally B Mansur | Lebanon | United States | 1 |